The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122763442 12276344 2 F 20150617 20160714 20160418 20160715 EXP DE-ROCHE-1599688 ROCHE 0.00 F Y 0.00000 20160715 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122763442 12276344 1 PS Rituximab RITUXIMAB 1 Intravenous (not otherwise specified) DATE OF LAST DOSE OF RITUXIMAB BEFORE SAE IS 10/DEC/2015. 103705 630 MG SOLUTION FOR INFUSION
122763442 12276344 2 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) U 0 QOW
122763442 12276344 3 SS DOXORUBICINE DOXORUBICIN 1 Intravenous (not otherwise specified) U 0
122763442 12276344 4 SS VINCRISTINE VINCRISTINE 1 Intravenous (not otherwise specified) 0
122763442 12276344 5 SS PREDNISONE. PREDNISONE 1 Oral DATE OF LAST DOSE BEFORE SAE 24/JUN/2015 U 0
122763442 12276344 6 SS Pegfilgrastim PEGFILGRASTIM 1 Subcutaneous U 0
122763442 12276344 7 C BISOPROLOL BISOPROLOL 1 Oral 0 2.5 MG QD
122763442 12276344 8 C PANTOPRAZOL PANTOPRAZOLE SODIUM 1 Oral 0 QD
122763442 12276344 9 C ENOXAPARIN SODIUM. ENOXAPARIN SODIUM 1 Subcutaneous 0 QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122763442 12276344 1 B-cell lymphoma
122763442 12276344 2 B-cell lymphoma
122763442 12276344 3 B-cell lymphoma
122763442 12276344 4 B-cell lymphoma
122763442 12276344 5 B-cell lymphoma
122763442 12276344 6 B-cell lymphoma
122763442 12276344 7 Cardiac failure
122763442 12276344 8 Prophylaxis against gastrointestinal ulcer
122763442 12276344 9 Pulmonary embolism

Outcome of event

Event ID CASEID OUTC COD
122763442 12276344 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
122763442 12276344 Hypotension
122763442 12276344 Interstitial lung disease
122763442 12276344 Malaise
122763442 12276344 Pneumonia aspiration
122763442 12276344 Pyrexia
122763442 12276344 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122763442 12276344 1 20150407 20150710 0
122763442 12276344 2 20150409 20150624 0
122763442 12276344 3 20150409 20150624 0
122763442 12276344 4 20150409 20150507 0
122763442 12276344 5 20150407 20150628 0
122763442 12276344 6 20150409 20150629 0
122763442 12276344 8 2015 0
122763442 12276344 9 201503 0